For the quarter ending 2026-03-28, MDLN made $7,352M in revenue. $129M in net income. Net profit margin of 1.75%.
| Income Statement | 2026-03-28 | 2025-12-31 | ||
|---|---|---|---|---|
| Net sales | 7,352 | 7,110* | ||
| Cost of goods sold | 5,511 | 5,229* | ||
| Gross profit | 1,841 | 1,881* | ||
| Selling, general and administrative expenses | 1,228 | 1,132* | ||
| Amortization of intangible assets | 176 | 176* | ||
| Other operating expenses | -15 | -19* | ||
| Total operating expense | 1,419 | 1,327* | ||
| Operating income | 422 | 554* | ||
| Interest expense, net | -136 | -203* | ||
| Other income, net | 1 | -16* | ||
| Foreign exchange gain (loss), net | 4 | -22* | ||
| Total other expense | -131 | -241* | ||
| Income before income taxes | 291 | 313* | ||
| Provision for income taxes | 52 | 23* | ||
| Net income | 239 | 290* | ||
| Net income attributable to noncontrolling interests | 110 | 0* | ||
| Net income attributable to medline inc | - | 290* | ||
| Retirement plan, net of tax | - | 2* | ||
| Net unrealized loss on derivative instruments | - | -22* | ||
| Currency translation adjustment | - | 32* | ||
| Total other comprehensive income (loss), net of tax | - | 8* | ||
| Total comprehensive income | - | 298* | ||
| Comprehensive loss attributable to noncontrolling interests | - | 0* | ||
| Comprehensive income attributable to medline inc | - | 298 | ||
| Net income attributable to medline inc | 129 | - | ||
| Basic EPS | 0.16 | 0.368 | ||
| Diluted EPS | 0.16 | 0.368 | ||
| Basic Average Shares | 819,000,000 | 810,000,000 | ||
| Diluted Average Shares | 825,000,000 | 810,000,000 | ||
Medline Inc. (MDLN)
Medline Inc. (MDLN)